-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Boston Scientific, Lowers Price Target to $61

Benzinga·07/30/2026 18:18:24
Listen to the news
Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $70 to $61.